10 Best Stocks Under $1 to Buy in 2025 – High-Potential Opportunities!
These low-priced stocks, also known as penny stocks, often fly under the radar, but that doesn't mean they lack potential. In fact, many investors have found success by buying penny stocks with solid growth prospects, making it a great time to dive into the market and find hidden gems.
Lets take a look at 10 of the best stocks under $1 in 2025 that are worth considering. We’ll go over each company, provide reasons for their potential, and explain why these stocks could be good buys for your portfolio. So, if you're looking to discover some great penny stocks to invest in, keep reading!
What Makes Stocks Under $1 Attractive?
Before diving into the individual stocks, let’s briefly discuss why investing in stocks under $1 can be appealing.
High Growth Potential: Many penny stocks are small-cap companies that have room to grow. If these companies can overcome challenges or tap into new opportunities, their stock prices could increase substantially.
Low Entry Price: Since penny stocks are priced low, you can buy a large number of shares without committing a significant amount of money. This can be appealing for investors looking to diversify their portfolios without risking too much.
Risk and Reward: Of course, investing in stocks under $1 comes with its risks. These companies are often in early stages, facing financial difficulties, or navigating volatile industries. However, the potential rewards can be immense if the company succeeds.
In the following sections, we’ll cover 10 stocks under $1 to watch in 2025. We’ll provide details like market cap, company overview, and why they have potential for growth. Let’s get started!
1. Inovio Pharmaceuticals (INO) – A Leader in Vaccine Development
Current Share Price: $0.80
Market Cap: $1.6 Billion
Inovio Pharmaceuticals is a biotech company that focuses on the development of DNA-based vaccines and immunotherapies. Despite its ups and downs, particularly with its COVID-19 vaccine trial, Inovio is still a key player in the vaccine development space.
Why It’s Worth Watching:
Inovio's potential for growth lies in its innovative approach to immunotherapy and its efforts in creating vaccines for a variety of diseases. The company has a number of promising programs in its pipeline, including vaccines for cancers and infectious diseases, which could significantly boost its share price if they succeed.
Additionally, Inovio’s partnership with large pharma companies like the Bill & Melinda Gates Foundation demonstrates its credibility within the medical community. The company's DNA vaccine platform has been shown to produce strong immune responses in animal studies, and if it succeeds in human trials, it could open up a new world of treatment options for various diseases.
Risks:
Like many biotech stocks, Inovio's future is highly dependent on the success of its clinical trials. There’s a chance the company’s products may not make it to market, or they could face setbacks that delay progress. Furthermore, regulatory approval is a lengthy process, which could impact the stock in the short term.
Nevertheless, with its focus on cutting-edge science and new vaccine technologies, Inovio Pharmaceuticals has the potential to surprise investors with a significant uptick in share price, especially as the world continues to focus on health and disease prevention.
Inovio Pharmaceuticals Overview
2. Zomedica Corp. (ZOM) – A Rising Star in Veterinary Medicine
Current Share Price: $0.60
Market Cap: $350 Million
Zomedica Corp. is a veterinary health company that focuses on developing innovative products for companion animals, particularly dogs and cats. The company’s main product, Truforma, is a diagnostic platform designed to help veterinarians diagnose pet health conditions more efficiently. Zomedica is at the forefront of a growing market, as pet owners are increasingly seeking advanced healthcare solutions for their pets.
Why It’s Worth Watching:
Zomedica’s innovative approach to veterinary diagnostics could revolutionize how veterinarians diagnose and treat pets. Truforma, which was launched in 2021, allows veterinarians to test for various health conditions, such as thyroid disease and adrenal disorders, providing quicker and more accurate results. This product could have massive implications for the pet healthcare market, as the demand for high-quality pet care continues to rise.
The veterinary sector is growing rapidly, driven by increased pet ownership and spending on pet health. As the market for pet care products continues to expand, Zomedica is well-positioned to capture a significant portion of the market with its cutting-edge technology.
Risks:
As a relatively new player in the market, Zomedica faces competition from established veterinary health companies. Furthermore, the success of Truforma is key to the company's future, and if the product doesn't perform as expected, it could have a significant impact on the stock price. Additionally, Zomedica’s revenue generation is still in its early stages, so it might take time for the company to reach profitability.
Despite the risks, Zomedica’s innovative approach to pet healthcare, combined with the growing demand for advanced veterinary products, makes it a stock to keep an eye on in 2025.
3. Ideanomics Inc. (IDEX) – A Play in the Electric Vehicle Market
Current Share Price: $0.98
Market Cap: $1 Billion
Ideanomics Inc. is a company that focuses on accelerating the adoption of electric vehicles (EVs) and sustainable energy solutions. Through its subsidiary, Mobile Energy Global, Ideanomics is helping to drive the transition to EVs by providing commercial fleets with the necessary tools, financing, and energy solutions. The company also has interests in financial technology and blockchain.
Why It’s Worth Watching:
The electric vehicle market is growing at an exponential rate, with governments and companies worldwide focusing on sustainability and reducing carbon emissions. Ideanomics is positioned to benefit from this trend, as it provides a comprehensive solution to the transition to electric fleets. The company offers EVs, charging infrastructure, and energy management solutions, making it an attractive player in the green energy space.
Ideanomics also has partnerships with several key players in the EV sector, including BYD (a leading Chinese EV manufacturer), which could help boost its presence in global markets. As more companies move toward electrification, Ideanomics could see substantial growth in demand for its products and services.
Risks:
Ideanomics is still in the early stages of its EV journey, and its revenue streams are diverse, which can create volatility. The company's stock price can be sensitive to the fluctuating prices of EVs and other green energy solutions. Additionally, there are numerous established players in the EV market, and Ideanomics faces stiff competition from larger companies with greater resources.
That said, if Ideanomics continues to secure partnerships and expands its reach in the growing EV and renewable energy markets, the stock could experience significant growth in 2025.
4. Sundial Growers Inc. (SNDL) – A Cannabis Stock to Watch
Current Share Price: $0.75
Market Cap: $330 Million
Sundial Growers Inc. is a Canadian cannabis company that focuses on the production and sale of cannabis products for the medical and adult-use markets. While Sundial was once primarily involved in growing and selling cannabis, the company has recently pivoted to focus on investing in other cannabis businesses. This shift in strategy could position Sundial for growth as the cannabis industry continues to evolve and mature.
Why It’s Worth Watching:
The cannabis market is expected to see substantial growth in the coming years as more regions legalize marijuana for medical and recreational use. Sundial, which is based in Canada, is in a good position to benefit from these market changes. The company’s recent investments in other cannabis companies could diversify its revenue streams and reduce its reliance on its own cultivation operations.
Sundial’s focus on improving its financial position and investing in the future of cannabis makes it a stock worth considering. If the company’s investments in other cannabis businesses pay off, it could lead to a substantial increase in stock price.
Additionally, Sundial has been focusing on becoming a profitable company by reducing costs and improving efficiencies in its operations. If these efforts succeed, the company could see a significant boost in investor confidence and stock performance.
Risks:
The cannabis industry is highly volatile, and companies like Sundial can be affected by changing regulations, market oversupply, and pricing pressures. Additionally, Sundial’s business model has shifted, which adds an element of uncertainty. If its investments in other cannabis businesses don’t yield returns, the company could face financial challenges.
Despite these risks, Sundial remains an intriguing opportunity, particularly if the cannabis market continues to expand globally. For those who are comfortable with higher-risk investments, Sundial could offer significant upside potential.
5. Genius Brands International, Inc. (GNUS) – A Play in Children’s Entertainment
Current Share Price: $0.60
Market Cap: $128 Million
Genius Brands International, Inc. is a global entertainment company that focuses on creating, producing, and licensing children’s media content. The company owns and operates popular brands like Rainbow Rangers and Stan Lee's Superhero Kindergarten, which are distributed worldwide. Genius Brands also has a streaming platform, Kartoon Channel!, which hosts content for kids, making it a key player in the growing kids’ entertainment space.
Why It’s Worth Watching:
Children’s entertainment is a huge market, with billions of dollars being spent annually on TV shows, toys, video games, and other content. Genius Brands, with its growing roster of popular shows and characters, is positioning itself to tap into this lucrative market.
The company’s strategic investments in content production and licensing deals with major partners like Netflix and Amazon Prime Video show that its intellectual property has appeal beyond traditional TV channels. The success of Stan Lee's Superhero Kindergarten has garnered attention, and with a growing library of content, Genius Brands could see significant growth as more families turn to streaming platforms for children's content.
Additionally, Kartoon Channel! is positioned to capture a share of the increasingly popular streaming space, especially as more consumers move away from traditional cable TV. The company’s commitment to expanding its streaming platform could lead to increased revenues and brand recognition in the coming years.
Risks:
As with any entertainment company, Genius Brands faces the challenge of producing content that resonates with both children and parents. The kids’ entertainment industry is highly competitive, and the company needs to continually innovate to maintain its market position.
Also, Genius Brands is a small-cap company with limited financial resources, which could make it harder for the company to compete against larger, better-funded competitors. However, if the company’s content gains traction and its streaming platform grows, it could become a profitable venture in the future.
6. Northern Dynasty Minerals Ltd. (NAK) – A Mining Play with Exploration Potential
Current Share Price: $0.90
Market Cap: $500 Million
Northern Dynasty Minerals Ltd. is a mining company focused on the development of its flagship project, the Pebble Project in Alaska. This project is one of the largest undeveloped copper-gold-silver-molybdenum deposits in the world. Despite its significant potential, the company has faced environmental opposition and regulatory hurdles, making it a controversial stock in the mining sector.
Why It’s Worth Watching:
Northern Dynasty's Pebble Project holds vast reserves of valuable metals, including copper and gold, which are essential to various industries, especially the growing green energy sector. As demand for electric vehicles and renewable energy increases, the demand for copper is expected to rise, which could make the Pebble Project a highly profitable asset in the future.
If Northern Dynasty can overcome its environmental and regulatory challenges, the Pebble Project could become a major player in the mining sector. The company is making progress in its efforts to secure permits and continue with the development of the project, and it has received support from investors who believe in the long-term value of the deposit.
Furthermore, Northern Dynasty's stock is significantly undervalued based on its large resource base. If the company can move forward with its project and unlock the value of its reserves, the stock could experience substantial growth.
Risks:
The biggest risk for Northern Dynasty is the regulatory and environmental opposition to the Pebble Project. If the company is unable to obtain the necessary permits or faces continued legal challenges, it could significantly delay or derail the project. Additionally, the mining industry is inherently risky, with fluctuations in commodity prices and operational challenges that can impact profitability.
However, if Northern Dynasty can navigate these hurdles, the potential upside from the Pebble Project makes it a stock worth keeping an eye on.
Northern Dynasty Minerals Overview
7. Acasti Pharma Inc. (ACST) – A Biotech Company with Cardiovascular Focus
Current Share Price: $0.85
Market Cap: $80 Million
Acasti Pharma Inc. is a biopharmaceutical company that focuses on the development of therapies for cardiovascular diseases. Its lead product, CaPre, is a novel omega-3 fatty acid drug that is aimed at treating severe hypertriglyceridemia (high triglyceride levels), a condition that can increase the risk of heart disease. Despite its small market cap, Acasti Pharma is a player in the growing cardiovascular treatment space.
Why It’s Worth Watching:
Acasti’s flagship drug, CaPre, has shown positive results in clinical trials, and if it gains FDA approval, it could capture a significant portion of the cardiovascular treatment market. The global cardiovascular disease market is massive, and drugs like CaPre that target specific risk factors, such as high triglycerides, have the potential to become highly sought-after treatments.
Additionally, omega-3 fatty acids have become widely recognized for their health benefits, and Acasti’s research into their use in treating heart conditions could provide the company with an edge over competitors. If CaPre passes the necessary regulatory hurdles, it could become a top-selling drug in the cardiovascular market, significantly boosting Acasti Pharma’s stock price.
Risks:
The main risk with Acasti Pharma is the reliance on CaPre and its ability to secure regulatory approval. The biopharma industry is highly competitive, and many drug candidates fail to meet FDA standards or face delays in approval. Additionally, Acasti’s small market cap and limited product pipeline make it more vulnerable to financial difficulties.
However, if CaPre is approved and achieves commercial success, Acasti Pharma could see considerable upside potential, especially in the growing cardiovascular market.
8. Mullen Automotive Inc. (MULN) – A Newcomer to the EV Market
Current Share Price: $0.50
Market Cap: $130 Million
Mullen Automotive Inc. is an electric vehicle (EV) manufacturer that focuses on developing and selling high-performance EVs for both the consumer and commercial markets. The company aims to provide affordable, eco-friendly alternatives to traditional gasoline-powered vehicles. With a portfolio of electric cars, including the Mullen 5 electric SUV, Mullen is positioning itself to compete in the rapidly growing EV industry.
Why It’s Worth Watching:
Mullen Automotive’s EV lineup shows promise, with the company working to deliver advanced technology at competitive prices. The Mullen 5 SUV, in particular, has garnered attention due to its sleek design, impressive range, and high-tech features. As consumer demand for electric vehicles continues to rise, Mullen could see significant growth if it can successfully deliver these vehicles to market.
The EV industry is booming, with automakers and new entrants alike racing to capture market share. Mullen, as a small-cap company, is still in the early stages of its growth, but it has the potential to become a major player if it can scale production and deliver high-quality vehicles. The company is also working on establishing a strong charging infrastructure and plans to expand its sales globally, which could further boost its growth prospects.
Risks:
Mullen Automotive faces significant competition from established EV manufacturers like Tesla, as well as other startups in the electric vehicle space. Moreover, as a smaller company, it may face challenges in securing the capital needed to scale production and distribution. The stock is also highly sensitive to market sentiment and overall EV market performance, making it a more volatile investment.
Despite these risks, Mullen’s innovative approach to affordable electric vehicles and its entry into the growing EV market make it a stock worth keeping an eye on in 2025.
9. Sierra Metals Inc. (SMT) – A Mining Company with Growth Potential
Current Share Price: $0.70
Market Cap: $220 Million
Sierra Metals Inc. is a mining company primarily focused on the exploration, extraction, and processing of precious and base metals, including silver, copper, zinc, and gold. The company operates several mining projects in Peru and Mexico, including the Bolivar and Cusi mines, which produce significant quantities of valuable metals. Sierra Metals is also engaged in various exploration activities, aiming to expand its reserves and resource base.
Why It’s Worth Watching:
Sierra Metals operates in the mining sector, which is expected to see growth as demand for metals like copper and silver increases, particularly due to the growing renewable energy and electric vehicle markets. Copper, in particular, is a key metal used in the manufacturing of electric vehicles, power grids, and renewable energy infrastructure, making Sierra Metals well-positioned to benefit from these trends.
The company is actively working to expand its production and increase its reserves through exploration, which could lead to further growth in the coming years. If Sierra Metals can successfully increase its output and secure new discoveries, it could see significant upside as metal prices rise.
Risks:
The mining industry is highly volatile, and Sierra Metals faces risks associated with fluctuating commodity prices, operational challenges, and geopolitical factors in the regions where it operates. Additionally, the company is still in the process of ramping up production and exploration, so any delays or setbacks could impact its stock price.
However, if Sierra Metals can continue to expand its operations and benefit from the rising demand for metals, particularly copper, the company could see strong growth in 2025 and beyond.
10. Canoo Inc. (GOEV) – A New Electric Vehicle Player
Current Share Price: $0.90
Market Cap: $650 Million
Canoo Inc. is an electric vehicle (EV) startup that focuses on designing and manufacturing electric vehicles for both commercial and consumer markets. The company has created a unique vehicle platform known as the Canoo platform, which can be adapted to create different types of EVs, including delivery vans and consumer vehicles. Canoo has also developed its own electric delivery vehicle, which is aimed at the growing e-commerce and logistics sectors.
Why It’s Worth Watching:
Canoo’s innovative approach to electric vehicle design makes it a company to watch in the rapidly growing EV market. Unlike traditional automakers, Canoo has developed a modular platform that allows for flexibility in vehicle design. This could give Canoo a competitive advantage by offering a broader range of EV models for different industries, including commercial delivery and fleet services, which are poised for significant growth in the coming years.
The demand for electric delivery vehicles is increasing as businesses look for more sustainable and cost-effective transportation options. Canoo’s entry into this market positions it well to capture a share of the growing electric vehicle fleet market. Moreover, the company has strategic partnerships with major players like Walmart, which has shown interest in using Canoo’s vehicles for its logistics operations.
Risks:
Canoo, like many EV startups, faces significant competition from both established automakers and other electric vehicle startups. While its platform is unique, the company is still in the process of scaling production, and there are questions about its ability to meet delivery targets and secure the necessary funding to scale operations. Additionally, Canoo is still working on proving its commercial viability and achieving profitability.
That said, if Canoo can successfully execute its production and delivery plans, it could become a major player in the electric vehicle space, particularly in the commercial fleet market.
This concludes the list of 10 promising stocks under $1 to consider for 2025. If you're looking to diversify your portfolio with some high-growth potential investments, these penny stocks could be worth exploring. However, as with any investment, it's essential to do thorough research and consider the risks involved. Always monitor Market Trends and Daily News About Different Industries..
Disclaimer: The information provided in this article is for educational purposes only and should not be considered financial advice. Please consult with a licensed financial advisor before making any investment decisions.
Frequently Asked Questions (FAQs) – Best Stocks Under $1 to Buy in 2025
Are Stocks Under $1 a Good Investment?
Yes, stocks under $1 can offer high-growth potential at a low entry cost. However, they also come with higher risk, as these companies are often in early stages or facing financial challenges.
What Are the Best Penny Stocks to Buy in 2025?
Some of the best stocks under $1 in 2025 include:
Inovio Pharmaceuticals (INO) – Vaccine innovation
Zomedica Corp. (ZOM) – Veterinary healthcare growth
Ideanomics Inc. (IDEX) – Electric vehicle investments
Sundial Growers (SNDL) – Expanding cannabis market
Mullen Automotive (MULN) – New EV industry player
What Makes Stocks Under $1 Risky?
Low-priced stocks are more volatile due to:
Lower liquidity – Harder to buy/sell large amounts
Financial instability – Many companies have unproven business models
Market sentiment-driven – Prone to sudden spikes and crashes
How Can I Find the Best Penny Stocks?
Look for stocks with:
✔ Strong growth potential (emerging industries like EVs & biotech)
✔ Positive financials & revenue growth
✔ Recent partnerships or acquisitions
✔ New product launches or innovations
Where Can I Buy Stocks Under $1?
You can buy penny stocks on:
eToro – Best for beginners
Robinhood – Commission-free trading
Interactive Brokers – Advanced trading tools
Fidelity – Offers OTC penny stocks
What Are the Best Sectors for Stocks Under $1?
Technology (AI & semiconductors)
Electric Vehicles & Renewable Energy
Biotech & Healthcare
5G & Telecommunications
How Long Should I Hold Penny Stocks?
Most investors buy penny stocks for short-term gains, but if a company has strong fundamentals, it may be worth holding long-term for significant growth.
Can Stocks Under $1 Reach $10 or More?
Yes, but only if the company achieves strong financial performance. Many large companies like Amazon and Tesla once traded at penny stock levels before skyrocketing in value.
What Are the Best Strategies for Penny Stock Investing?
Diversify – Don’t put all your money in one stock
Research the company’s financials & news
Avoid hype & pump-and-dump schemes
Use stop-loss orders to limit risk
What Is the Biggest Mistake Penny Stock Investors Make?
Chasing hype without research – Many penny stocks are promoted in pump-and-dump schemes.
Investing too much money – Always limit exposure to high-risk stocks.
Ignoring liquidity – Some penny stocks have very low trading volume, making them hard to sell.
Posts
Comments
Post a Comment